WASHINGTON, July 27, 2017 -- Today, Senate Appropriations Committee Chairman Thad Cochran (R-MS) and Commerce, Justice and Science Appropriations Subcommittee Chairman Richard Shelby (R-AL) confirmed that they added language to the FY2018 Commerce, Justice and Science Subcommittee bill to ensure that the Seafood Import Monitoring Program for shrimp is fully implemented on the same timeline with all other species. This CJS bill was passed by the full Senate Appropriations today.
“We are so pleased that Chairmen Cochran and Shelby inserted language in the Senate CJS Appropriations bill to make sure that shrimp is included in this important program to provide traceability of U.S. seafood imports,” noted Dr. David Veal, Executive Director of the American Shrimp Processors Association. “They understand that since shrimp comprises 65 percent of U.S. seafood imports, it is vital that the species is included in the program,” Veal added.
“Chairmen Cochran and Shelby showed once again today that they care about the survival of the U.S. shrimp industry and continued economic opportunity and job growth for coastal Gulf communities,” said Edward T. Hayes, Gulf Counsel for the American Shrimp Processors Association. “This measure will make sure that the health and safety of the American consumer is foremost when it comes to aquaculture shrimp imports,” he also noted.
“Including shrimp in the Seafood Import Monitoring Program will help with trade enforcement by making it easier to combat import fraud,” continued Dr. Veal. “We also appreciate that Secretary Wilbur Ross and the U.S. Commerce Department are working very hard to implement the rule on the overall program,” he added.
“The leaders of NOAA and of the Commerce Department understand that illegal, unreported and unregulated (IUU) foreign fisheries cause harm for consumers and the domestic seafood industry. We are also grateful for the broad support of the rule by Gulf State Senators. We commend Senator Bill Cassidy (R-LA) in particular for leading two Senate letters on this topic, which clearly moved the ball forward. It is nice to see the Congress and the Trump Administration team up on this issue,” Hayes concluded.
About the American Shrimp Processors Association: The American Shrimp Processors Association (ASPA), based in Biloxi, Mississippi, was formed in 1964 to represent and promote the interests of the domestic, U.S. wild-caught, warm water shrimp processing industry along the Gulf Coast with members from Texas, Louisiana, Mississippi, Alabama and Florida. We are the collective voice of the industry, and our focus is to promote the interests of shrimp processors, other segments of the U.S. domestic wild-caught shrimp industry and the general public.
Contact: Dr. David C. Veal | Executive Director ASPA | [email protected] | 228.806.9600


California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Italy Fines Apple €98.6 Million Over App Store Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 



